Teva Executive and Leadership Team

Vitaliy Gayduchenko, the Chief Financial Officer at Teva, directs the company's overall financial strategy and operations. This leadership position involves managing Teva's global financial health, ensuring fiscal responsibility, and optimizing resource allocation across all business units. Gayduchenko oversees budgeting, forecasting, and financial reporting, providing critical insights that inform executive decision-making. The role demands a deep understanding of the biopharmaceutical industry's financial complexities, including market dynamics, regulatory impacts, and investment opportunities. By maintaining robust financial controls and driving efficiency, Vitaliy Gayduchenko supports Teva's mission to improve health outcomes and expand access to medicines worldwide. This executive ensures the financial infrastructure aligns with the company's strategic goals for growth and innovation in both established generics and novel therapeutic solutions.

Eli Kalif, the Chief Financial Officer & Executive VP at Teva, holds comprehensive responsibility for the company's global financial architecture and strategic fiscal direction. This executive VP role encompasses overseeing all financial planning, accounting, treasury functions, and investor relations, ensuring robust financial health and compliance across Teva's diverse operations. Kalif's leadership drives the financial strategies that support Teva's mission to improve health outcomes by developing, manufacturing, and delivering a broad portfolio of medicines. The scope of this position includes managing complex financial models for generics, biosimilars, and innovative therapies, while also guiding investment in scientific research and operational efficiency. By ensuring fiscal discipline and strategic financial management, Eli Kalif is pivotal in expanding access to quality medicines and advancing Teva's commitment to addressing unmet patient needs worldwide.

Efi Benmeir, the Senior VP, Finance & Chief Financial Officer, International Markets at Teva, directs financial operations and strategy across Teva's global markets outside of core regions. This senior leadership role involves managing financial planning, analysis, and reporting for diverse international territories, ensuring fiscal alignment with global objectives. Benmeir oversees the financial performance of Teva's extensive portfolio, including generics, biosimilars, and innovative therapies, within these key international markets. The position requires navigating varied economic landscapes and regulatory environments to optimize financial outcomes and drive sustainable growth. By providing strategic financial guidance and ensuring operational efficiency, Efi Benmeir supports Teva's overarching mission to improve health outcomes and expand access to essential medicines on a global scale, directly contributing to the company's commitment to addressing unmet patient needs.

Fernando Rodrigo, the Director, Finance & Chief Financial Officer at Teva, manages critical financial functions and contributes to strategic fiscal planning. This role involves overseeing specific financial operations, ensuring accuracy in reporting, and supporting budget management for key business segments. Rodrigo's responsibilities include analyzing financial data to identify trends and opportunities that align with Teva's mission of improving health outcomes. The position requires a detailed understanding of financial principles to support the development, manufacturing, and delivery of Teva's diverse medicine portfolio. By ensuring sound financial practices and contributing to strategic decision-making, Fernando Rodrigo plays a part in Teva's commitment to expanding access to quality medicines and addressing unmet patient needs through scientific research and efficient treatment solutions.

Nishank Bhargava, the Regional Director, Finance & Chief Financial Officer (India) at Teva, leads financial strategy and operations within the Indian market. This executive role involves managing all aspects of financial planning, accounting, and compliance specific to Teva's operations in India. Bhargava ensures that financial resources are effectively allocated to support the development, manufacturing, and distribution of Teva's broad medicine portfolio, including generics and innovative therapies, within the region. The position demands expertise in local market dynamics and regulatory frameworks to drive financial performance and operational efficiency. By providing strategic financial oversight, Nishank Bhargava contributes significantly to Teva's mission of improving health outcomes and expanding access to quality medicines in India, reinforcing the company's dedication to addressing unmet patient needs.

Efrat Yehudai, the Senior Vice President, Chief Financial Officer ) Teva Global Operations( ( Tech Operations) at Teva, directs financial strategy and oversight for Teva's global technology and operations divisions. This critical role involves managing the financial health and resource allocation for Teva's extensive manufacturing, supply chain, and technological infrastructure. Yehudai's responsibilities include developing financial plans, optimizing operational expenditures, and ensuring fiscal discipline across complex global operations. The position requires a deep understanding of the financial intricacies involved in producing and delivering a broad portfolio of medicines, from established generics to advanced therapeutic solutions. By driving financial efficiency and strategic investment in technology and operations, Efrat Yehudai supports Teva's mission to improve health outcomes and expand access to quality medicines worldwide, reinforcing the company's commitment to scientific research and patient care.

Yehuda Koren, the Director, Financial & Chief Financial Officer, S L E at Teva, oversees financial operations and strategic planning for the S L E division. This leadership position involves managing the financial health and resource allocation within this specific business unit, ensuring alignment with Teva's broader corporate objectives. Koren's responsibilities include financial analysis, budgeting, and reporting, providing critical insights to guide decision-making for S L E's contributions to Teva's medicine portfolio. The role demands a thorough understanding of financial principles to support the development and delivery of treatments. By ensuring fiscal responsibility and strategic financial management within the S L E division, Yehuda Koren contributes to Teva's mission of improving health outcomes and expanding access to quality medicines, supporting the company's dedication to addressing unmet patient needs through scientific advancement.

Dov Primovitch, the Chief Financial Officer (Israel) at Teva, leads financial strategy and operations within Teva's home market. This executive role encompasses managing all financial planning, accounting, treasury, and reporting functions for Teva's Israeli operations. Primovitch ensures that financial resources are strategically deployed to support the development, manufacturing, and distribution of Teva's diverse medicine portfolio, including generics, biosimilars, and innovative therapies, within Israel. The position requires navigating the specific economic and regulatory landscape of the region to optimize financial performance and drive operational efficiency. By providing expert financial oversight and strategic guidance, Dov Primovitch plays a crucial role in Teva's mission to improve health outcomes and expand access to quality medicines in Israel, reinforcing the company's commitment to addressing unmet patient needs.

Martin Laughlin, the Chief of Staff and Head of Commercial Excellence at Teva, spearheads initiatives to enhance commercial operations and strategic execution. This role involves optimizing sales processes, driving market penetration, and ensuring alignment across global commercial teams. Laughlin focuses on developing and implementing best practices that elevate Teva's market presence and customer engagement. The position requires close collaboration with various departments to streamline go-to-market strategies and foster a culture of continuous improvement. By refining commercial frameworks and driving operational efficiency, Martin Laughlin directly contributes to Teva's ability to deliver a broad portfolio of medicines, including complex generics and innovative therapies. The focus is on maximizing commercial impact and supporting the company's dedication to addressing unmet patient needs through scientific research and expanded access to quality treatments.

Alicia Logan, the Chief of Staff & Senior Director, Commercial Excellence at Teva, enhances the effectiveness and efficiency of Teva's commercial operations. This role focuses on refining commercial strategies, implementing best practices, and ensuring seamless execution across global sales and marketing functions. Logan works to optimize processes that support the delivery of Teva's broad medicine portfolio, from complex generics to innovative therapies. The position involves close collaboration with leadership to drive strategic initiatives and foster a culture of high performance within commercial teams. By improving operational frameworks and ensuring strategic alignment, Alicia Logan directly contributes to Teva's mission of improving health outcomes and expanding access to quality medicines. This leadership ensures that commercial efforts effectively support the company's dedication to addressing unmet patient needs through scientific advancement and streamlined treatment delivery.